MINIject® is intended to be used to reduce intraocular pressure (IOP) by channelling aqueous humour out of the anterior chamber to the supraciliary space, thus enhancing physiological uveoscleral outflow.
MINIject® is indicated in adult patients diagnosed with open angle glaucoma.
MINIject™ is contraindicated if one or more of the following conditions exist:
The MINIject™ implant is intended for long-term use. The physician should monitor the patient postoperatively for proper maintenance of IOP as performance may change over time. If IOP is not adequately maintained, the physician should consider appropriate additional therapy to maintain the target IOP.
The MINIject™ implant is composed of a porous medical-grade silicone it is 5.0 mm long with an oblong cross section of 1.1 x 0.6 mm. The parts of the Delivery System that enter the eye during surgery are made of medical-grade polyimide and medical-grade stainless steel. These Delivery System parts have only transient contact with eye tissues.
The MINIject implant is magnetic resonance (MR) Safe: the implant is constructed of silicone, a non-conducting, non-metallic, non-magnetic material that poses no known hazards in all magnetic resonance imaging environments.
For more information, please request the latest Summary of Safety and Clinical Performance on our contact page.